1970—2019年广东省中山市鼻咽癌发病和死亡分析

Incidence and Mortality of Nasopharyngeal Carcinoma in Zhongshan City of Guangdong Province,1970—2019

[目的]分析研究1970—2019年广东省中山市鼻咽癌的发病和死亡资料,为中山市鼻咽癌的防治提供科学依据。[方法]收集并整理1970—2019年广东省中山市鼻咽癌发病和死亡资料,统计分析其发病和死亡数、粗率、年龄别率和标化率等指标。[结果]1970—2019年广东省中山市鼻咽癌新发11302例,发病粗率、中标率和世标率分别为18.11/10万、14.67/10万和17.61/10万。死亡6919例,死亡粗率、中标率和世标率分别为11.09/10万、8.76/10万和11.09/10万,男性发病率和死亡率均高于女性,发病和死亡粗率总体上升,中标率与世标率总体下降。鼻咽癌年龄别发病率和死亡率分别从20岁和30岁左右开始迅速上升,分别于55~59岁和60~64岁年龄组达高峰,不同时段年龄别发病率和死亡率变化模式基本相同。[结论]虽然1970—2019年广东省中山市鼻咽癌标化发病率和死亡率总体下降,但其粗率上升,且近期其发病和死亡仍居全球和我国较高水平,提示中山市仍应重视鼻咽癌防治。

[Purpose]To analyze the incidence and mortality of nasopharyngeal carcinoma(NPC)in Zhongshan City of Guangdong Province during 1970—2019.[Methods]NPC incidence and death data in Zhongshan City during 1970—2019 were collected.The crude incidence and mortality rates,age-specific and age-standardized rates(ASRs)were calculated and analyzed.[Results]There were 11302 new NPC cases in Zhongshan City during 1970—2019,the crude incidence rate was 18.11/105,ASRs by Chinese and world standard populations were 14.67/105 and 17.61/105,respectively.There were 6919 NPC death cases,the crude mortality rate was 11.09/105,ASRs by Chinese and world standard populations were 8.76/105 and 11.09/105,respectively.The incidence and mortality in male were higher than those in female.There was a rising trend of crude incidence and mortality and a downward trend of ASRs of incidence and mortality during 1970—2019.The age-specific incidence and mortality rates increased from the age group of 20 and 30 years,peaked at the age group of 55~59 and 60~64 years,respectively,with basically the same patterns in different periods.[Conclusion]Although the crude incidence rates of NPC significantly increased in Zhongshan City during 1970—2019,generally there was a decreasing trend for the NPC incident and death ASRs as a whole,but its incidence and mortality are still at high levels nationwide and worldwide.It suggests that NPC control and prevention in Zhongshan City should be enhanced further.